AVXL
Price:
$2.73
Market Cap:
$252.99M
Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's disease and is being explored in preclinical studies for a wider range of disorders, including epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. Another significant drug candidate, ANAVEX 3-71, has progressed to...[Read more]
Industry
Biotechnology
IPO Date
2006-08-02
Stock Exchange
NASDAQ
Ticker
AVXL
According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -5.93. This represents a change of -63.55% compared to the average of -16.27 of the last 4 quarters.
The mean historical PE Ratio of Anavex Life Sciences Corp. over the last ten years is -13.20. The current -5.93 PE Ratio has changed 4.39% with respect to the historical average. Over the past ten years (40 quarters), AVXL's PE Ratio was at its highest in in the December 2018 quarter at -2.44. The PE Ratio was at its lowest in in the June 2021 quarter at -40.82.
Average
-13.20
Median
-10.92
Minimum
-33.24
Maximum
-5.85
Discovering the peaks and valleys of Anavex Life Sciences Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.75%
Maximum Annual PE Ratio = -5.85
Minimum Annual Increase = -49.93%
Minimum Annual PE Ratio = -33.24
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -16.48 | 50.89% |
| 2024 | -10.92 | 0.06% |
| 2023 | -10.92 | -34.42% |
| 2022 | -16.65 | -49.93% |
| 2021 | -33.24 | 228.75% |
| 2020 | -10.11 | 72.78% |
| 2019 | -5.85 | -11.54% |
| 2018 | -6.62 | -47.27% |
| 2017 | -12.55 | 45.15% |
| 2016 | -8.64 | -0.39% |
The current PE Ratio of Anavex Life Sciences Corp. (AVXL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.77
5-year avg
-17.64
10-year avg
-13.20
Anavex Life Sciences Corp.’s PE Ratio is greater than Erasca, Inc. (-14.70), greater than MeiraGTx Holdings plc (-7.65), less than MoonLake Immunotherapeutics (-4.95), less than Arvinas, Inc. (-2.35), greater than MBX Biosciences, Inc. Common Stock (-19.56), less than Astria Therapeutics, Inc. (-5.88), greater than CytomX Therapeutics, Inc. (-8.17), less than Valneva SE (-2.84), less than REGENXBIO Inc. (-1.39), greater than Absci Corporation (-8.93),
| Company | PE Ratio | Market cap |
|---|---|---|
| -14.70 | $4.25B | |
| -7.65 | $1.05B | |
| -4.95 | $1.41B | |
| -2.35 | $494.88M | |
| -19.56 | $1.45B | |
| -5.88 | $718.13M | |
| -8.17 | $474.43M | |
| -2.84 | $510.15M | |
| -1.39 | $403.24M | |
| -8.93 | $1.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Anavex Life Sciences Corp.'s PE Ratio?
How is the PE Ratio calculated for Anavex Life Sciences Corp. (AVXL)?
What is the highest PE Ratio for Anavex Life Sciences Corp. (AVXL)?
What is the 3-year average PE Ratio for Anavex Life Sciences Corp. (AVXL)?
What is the 5-year average PE Ratio for Anavex Life Sciences Corp. (AVXL)?
How does the current PE Ratio for Anavex Life Sciences Corp. (AVXL) compare to its historical average?